CICLOPIROX - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ciclopirox and what is the scope of patent protection?
Ciclopirox
is the generic ingredient in three branded drugs marketed by Cosette, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Medimetriks Pharms, Alvogen, Glenmark Pharms Inc, Padagis Us, Actavis Mid Atlantic, Encube, Bausch, Acella, Chartwell Rx, Epic Pharma Llc, Hikma, Mylan Pharms Inc, Rising, Taro Pharm Inds, Teva Pharms, and Valeant Bermuda, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for ciclopirox. Sixteen suppliers are listed for this compound.
Summary for CICLOPIROX
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 21 |
NDAs: | 32 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 16 |
Raw Ingredient (Bulk) Api Vendors: | 107 |
Clinical Trials: | 13 |
Patent Applications: | 6,712 |
Drug Prices: | Drug price trends for CICLOPIROX |
Drug Sales Revenues: | Drug sales revenues for CICLOPIROX |
What excipients (inactive ingredients) are in CICLOPIROX? | CICLOPIROX excipients list |
DailyMed Link: | CICLOPIROX at DailyMed |
Recent Clinical Trials for CICLOPIROX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Universidad Complutense de Madrid | Phase 4 |
Atlas Molecular Pharma | Phase 1 |
BritaMed, Inc. | N/A |
Pharmacology for CICLOPIROX
Mechanism of Action | Protein Synthesis Inhibitors |
Physiological Effect | Decreased DNA Replication Decreased Protein Synthesis Decreased RNA Replication |
Anatomical Therapeutic Chemical (ATC) Classes for CICLOPIROX
Paragraph IV (Patent) Challenges for CICLOPIROX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CICLOPIROX | Gel | ciclopirox | 0.77% | 020519 | 1 | 2006-05-10 |
US Patents and Regulatory Information for CICLOPIROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Padagis Us | CICLOPIROX | ciclopirox | GEL;TOPICAL | 078266-001 | Jan 7, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Glenmark Pharms Inc | CICLOPIROX | ciclopirox | GEL;TOPICAL | 091595-001 | Feb 29, 2012 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Medimetriks Pharms | LOPROX | ciclopirox | CREAM;TOPICAL | 018748-001 | Dec 30, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Fougera Pharms | CICLOPIROX | ciclopirox | GEL;TOPICAL | 077896-001 | Jun 10, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CICLOPIROX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Medimetriks Pharms | LOPROX | ciclopirox | CREAM;TOPICAL | 018748-001 | Dec 30, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | LOPROX | ciclopirox | SHAMPOO;TOPICAL | 021159-001 | Feb 28, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | LOPROX | ciclopirox | SHAMPOO;TOPICAL | 021159-001 | Feb 28, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Medimetriks Pharms | LOPROX | ciclopirox | SUSPENSION;TOPICAL | 019824-001 | Dec 30, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.